1. Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
- Author
-
Mavromanoli AC, Jiménez D, Sanchez O, Sobkowicz B, Vanni S, Kurzyna M, Becattini C, Pruszczyk P, Wilkens H, Bova C, Tschöpe C, Sawicka-Śmiarowska E, Grifoni C, Kostrubiec M, Torbicki A, Meneveau N, Kresoja KP, and Konstantinides SV
- Subjects
- Humans, Hemorrhage chemically induced, Thrombolytic Therapy, Fibrinolytic Agents adverse effects, Treatment Outcome, Pulmonary Embolism complications, Pulmonary Embolism drug therapy
- Abstract
Competing Interests: Declaration of competing interest OS reports grants or contracts from Bayer, BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo and MSD; consulting fees from BMS/Pfizer, Sanofi, Inari and Boston; and payment or honoraria from BMS/Pfizer, Sanofi, Inari, Bayer, Boston and MSD. MKu reports payment or honoraria from Bayer, Pfizer and Boehringer Ingelheim. CBe reports consulting fees from Bayer HealthCare, Bristol Myers Squibb, Pfizer and Daiichi Sankyo; and payment or honoraria from Bayer HealthCare, Bristol Myers Squibb and Pfizer. PP reports support for attending meetings and/or travel from Boehringer Ingelheim, Bayer and Pfizer. HW reports consulting fees from Bayer, Biotest, Boehringer Ingelheim, Pfizer, GSK, Janssen, MSD and Roche; and payment or honoraria from Bayer, Biotest, Boehringer Ingelheim, Janssen and MSD. AT reports grants or contracts from Bayer HealthCare, Pfizer, Janssen and MSD; consulting fees from Bayer, Pfizer, Janssen and MSD; payment or honoraria from AOP, Bayer, Pfizer, MSD, United Therapeutics and Ferrer; support for attending meetings and/or travel from Pfizer; and participation on a Data Safety Monitoring Board or Advisory Board for Janssen and Boston Scientific. NM reports grants or contracts from Bayer HealthCare, BMS Pfizer, Medtronic, Boston Scientific and Inari; consulting fees from BMS Pfizer, Terumo, Siemens, Abbott and Boston Scientific; and payment or honoraria from Astra Zeneca, Siemens, Terumo, Bayer HealthCare, BMS Pfizer and Abbott. K-PK reports payment or honoraria and participation on an Advisory Board from Edwards LifeScience. SVK reports consulting fees from Daiichi Sankyo, Bayer AG and Boston Scientific; and payment or honoraria from Bristol-Myers Squibb – Pfizer, Boston Scientific and MSD. All other authors (ACM, DJ, BS, SV, CBo, CT, ES-S, CG, MKo) declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF